Show simple item record

dc.contributor.authorPendergrass, Sarah A.en_US
dc.contributor.authorHayes, Everetten_US
dc.contributor.authorFarina, Giuseppinaen_US
dc.contributor.authorLemaire, Raphaelen_US
dc.contributor.authorFarber, Harrison W.en_US
dc.contributor.authorWhitfield, Michael L.en_US
dc.contributor.authorLafyatis, Roberten_US
dc.date.accessioned2012-01-09T21:04:07Z
dc.date.available2012-01-09T21:04:07Z
dc.date.issued2010-8-17en_US
dc.identifier.citationPendergrass, Sarah A., Everett Hayes, Giuseppina Farina, Raphael Lemaire, Harrison W. Farber, Michael L. Whitfield, Robert Lafyatis. "Limited Systemic Sclerosis Patients with Pulmonary Arterial Hypertension Show Biomarkers of Inflammation and Vascular Injury" PLoS ONE 5(8): e12106. (2010)en_US
dc.identifier.issn1932-6203en_US
dc.identifier.urihttp://hdl.handle.net/2144/2982
dc.description.abstractBACKGROUND. Pulmonary arterial hypertension (PAH) is a common complication for individuals with limited systemic sclerosis (lSSc). The identification and characterization of biomarkers for lSSc-PAH should lead to less invasive screening, a better understanding of pathogenesis, and improved treatment. METHODS AND FINDINGS. Forty-nine PBMC samples were obtained from 21 lSSc subjects without PAH (lSSc-noPAH), 15 lSSc subjects with PAH (lSSc-PAH), and 10 healthy controls; three subjects provided PBMCs one year later. Genome-wide gene expression was measured for each sample. The levels of 89 cytokines were measured in serum from a subset of subjects by Multi-Analyte Profiling (MAP) immunoassays. Gene expression clearly distinguished lSSc samples from healthy controls, and separated lSSc-PAH from lSSc-NoPAH patients. Real-time quantitative PCR confirmed increased expression of 9 genes (ICAM1, IFNGR1, IL1B, IL13Ra1, JAK2, AIF1, CCR1, ALAS2, TIMP2) in lSSc-PAH patients. Increased circulating cytokine levels of inflammatory mediators such as TNF-alpha, IL1-beta, ICAM-1, and IL-6, and markers of vascular injury such as VCAM-1, VEGF, and von Willebrand Factor were found in lSSc-PAH subjects. CONCLUSIONS AND SIGNIFICANCE. The gene expression and cytokine profiles of lSSc-PAH patients suggest the presence of activated monocytes, and show markers of vascular injury and inflammation. These genes and factors could serve as biomarkers of PAH involvement in lSSc.en_US
dc.description.sponsorshipActelion Pharmaceuticals Ltd; Arthritis Foundation (Hulda Irene Duggan Arthritis Investigator Award, T32 AR007575-11)en_US
dc.language.isoenen_US
dc.publisherPublic Library of Scienceen_US
dc.rightsPendergrass et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.en_US
dc.titleLimited Systemic Sclerosis Patients with Pulmonary Arterial Hypertension Show Biomarkers of Inflammation and Vascular Injuryen_US
dc.typearticleen_US
dc.identifier.doi10.1371/journal.pone.0012106en_US
dc.identifier.pubmedid20808962en_US
dc.identifier.pmcid2923145en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record